SciSparc secures Canadian patent for pain treatment

TEL AVIV - SciSparc Ltd. (NASDAQ:SPRC), a pharmaceutical company specializing in central nervous system disorders and rare diseases, has received a Canadian patent for a novel combination of opioids and n-acylethanolamines intended for pain management. The Canadian Intellectual Property Office granted the patent, signaling a potential advancement in the approach to treating chronic pain amid...

Read More

CAC 40 Slides As US Deficit Worries Grow

French stocks were slightly lower on Tuesday amid rising inflation expectations and concerns over U.S. fiscal deficit. With about two weeks left before the Nov. 5 election, Treasury yields remained elevated on concerns about the path of the U.S. deficit regardless of which candidate wins the race for the White House. The benchmark CAC 40...

Read More

Higher Open Called For Taiwan Stock Market

The Taiwan stock market has moved higher in three straight sessions, collecting almost 625 points or 2.8 percent along the way. The Taiwan Stock Exchange now sits just above the 22,280-point plateau and it may see additional support on Tuesday. The global forecast for the Asian markets suggests mild upside, largely on positive momentum amid...

Read More